» Articles » PMID: 17974863

Agitation and Psychosis in Dementia

Overview
Publisher Elsevier
Specialty Geriatrics
Date 2007 Nov 3
PMID 17974863
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Characteristics of clinical-pharmacological recommendations in psychiatry in Germany.

Schroder S, Schulze Westhoff M, Pfister T, Bleich S, Wedegartner F, Kruger T Int J Psychiatry Med. 2023; 59(3):393-405.

PMID: 37194304 PMC: 11044510. DOI: 10.1177/00912174231177230.


Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress.

Magierski R, Sobow T, Schwertner E, Religa D Front Pharmacol. 2020; 11:1168.

PMID: 32848775 PMC: 7413102. DOI: 10.3389/fphar.2020.01168.


Management of Neuropsychiatric Symptoms in Neurocognitive Disorders.

Legesse B, Babadi B, Forester B Focus (Am Psychiatr Publ). 2020; 15(1):18-25.

PMID: 31975836 PMC: 6519624. DOI: 10.1176/appi.focus.20160031.


Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

Wang L, Shofer J, Rohde K, Hart K, Hoff D, McFall Y Am J Geriatr Psychiatry. 2009; 17(9):744-51.

PMID: 19700947 PMC: 2842091. DOI: 10.1097/JGP.0b013e3181ab8c61.


Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?.

Lavretsky H Am J Geriatr Psychiatry. 2008; 16(7):523-7.

PMID: 18591572 PMC: 2806814. DOI: 10.1097/JGP.0b013e318178416c.